HNP Capital’s Eli Lilly LLY Stock Holding History

HNP Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.53M	Sell	4,466 -200	-4%	-$67.5K	0.43%	62
2022 Q4	$1.71M	Hold	4,666	–	–	0.48%	57
2022 Q3	$1.51M	Hold	4,666	–	–	0.44%	60
2022 Q2	$1.51M	Hold	4,666	–	–	0.42%	63
2022 Q1	$1.34M	Hold	4,666	–	–	0.32%	75
2021 Q4	$1.29M	Buy	4,666 +36	+0.8%	+$9.13K	0.29%	76
2021 Q3	$1.07M	Hold	4,630	–	–	0.27%	82
2021 Q2	$1.06M	Hold	4,630	–	–	0.28%	83
2021 Q1	$865K	Hold	4,630	–	–	0.26%	85
2020 Q4	$782K	Hold	4,630	–	–	0.26%	81
2020 Q3	$661K	Buy	4,630 +650	+16%	+$101K	0.24%	81
2020 Q2	$652K	Buy	+3,980	New	+$611K	0.27%	76
2020 Q1	–	Sell	-3,980	Closed	-$549K	–	288
2019 Q4	$549K	Hold	3,980	–	–	0.23%	73
2019 Q3	$427K	Hold	3,980	–	–	0.23%	76
2019 Q2	$441K	Hold	3,980	–	–	0.26%	73
2019 Q1	$516K	Hold	3,980	–	–	0.32%	68
2018 Q4	$461K	Buy	+3,980	New	+$445K	0.31%	68

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HNP Capital's LLY Position: Q1 2023 in Review

HNP Capital reduced its Eli Lilly (LLY) stake by 4.3% in Q1 2023, selling an estimated $67.5K and leaving 4,466 shares worth $1.53M. The position accounts for 0.43% of the portfolio, ranked #62.

HNP Capital first reported a position in LLY in Q4 2018 and has held it in 17 quarters since. The position peaked at $1.71M in Q4 2022. 2,614 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

HNP Capital held 4,466 shares of Eli Lilly worth $1.53M as of Q1 2023.
HNP Capital sold 200 Eli Lilly shares in Q1 2023, an estimated $67.5K.
Eli Lilly made up 0.43% of HNP Capital's portfolio in Q1 2023, its #62 holding.
HNP Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 17 quarters since.
HNP Capital's Eli Lilly position peaked at $1.71M in Q4 2022.
2,614 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.